Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06767332

EMDR for Fear of Cancer Recurrence in Patients with Familial Melanoma: a Waiting List Control Trial

Led by Leiden University Medical Center · Updated on 2025-01-09

30

Participants Needed

2

Research Sites

113 weeks

Total Duration

On this page

Sponsors

L

Leiden University Medical Center

Lead Sponsor

E

Erasmus Medical Center

Collaborating Sponsor

AI-Summary

What this Trial Is About

High fear of cancer recurrence (FCR) impacts patient's quality of life (QoL) and is prevalent among patients with familial melanoma. The main objective is to investigate whether EMDR is effective in treating high FCR in patients with familial melanoma. The study design is a non-blinded, randomized waiting-list controlled trial. Patients aged 18 years or older with familial melanoma can be included. Patients with high FCR will receive a maximum of 4, 90 minutes, EMDR-sessions. The main study parameter is the decrease and level of FCR measured with the Cancer Worry Scale (CWS). The secondary study parameter is quality of life, measured with the EORTC.

CONDITIONS

Official Title

EMDR for Fear of Cancer Recurrence in Patients with Familial Melanoma: a Waiting List Control Trial

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • A score of 16 or higher on the FCRI-NL-SF
  • 18 years or older
  • Diagnosed with familial melanoma
Not Eligible

You will not qualify if you...

  • Insufficient knowledge of the Dutch language
  • Acute psychiatric disease such as psychosis or suicidal ideation
  • Variable dose of anxiolytic medication

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Leiden University Medical Center

Leiden, South Holland, Netherlands, 2333ZA

Actively Recruiting

2

Leiden University Medical Centre

Leiden, South Holland, Netherlands, 2333ZA

Actively Recruiting

Loading map...

Research Team

S

Sanne K. de Bie, Drs.

CONTACT

C

Chris Hinnen, Dr.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here